CLINICAL_TRIALS
trial_result
· 2022-10-27
Clinical Trial Update: A Study of LY3209590 in Participants With Type 1 Diabetes [Phase 2]
Summary
Phase 2 clinical trial update for LY3209590 in participants with Type 1 Diabetes mellitus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2022-10-27